Policy Notices

• Reminder: AHRQ Natural Disaster Policy Hurricane Laura, Derecho
  (NOT-HS-20-015)
  Agency for Healthcare Research and Quality
  

General Notices

• Pre-Application Webinar for NCI Pediatric In Vivo Testing Program and NCI Pediatric In Vivo Testing Program Coordinating Center (RFA-CA-20-034, RFA-CA-20-041)
  (NOT-CA-20-096)
  National Cancer Institute
  

• Pre-Application Webinars for RFA-CA-20-047, Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
  (NOT-CA-20-097)
  National Cancer Institute
  

• Pre-Application Webinar for RFA-ES-20-001 "Collaborative Centers in Children's Environmental Health Research and Translation (P2C Clinical Trial Optional)"
  (NOT-ES-20-022)
  National Institute of Environmental Health Sciences
  

• Notice of Applicant Information Webinar and Frequently Asked Questions (FAQs) for Investigator-Initiated Research on Genetic Counseling Processes and Practices Request for Applications (RFAs): RFA-HG-20-048 and RFA-HG-20-049
  (NOT-HG-20-057)
  National Human Genome Research Institute
  

• Notice of Intent to Publish Funding Opportunity Announcement to Improve the Nonsurgical Management of Urinary Incontinence in Women
  (NOT-HS-20-014)
  Agency for Healthcare Research and Quality
  

Notice of Changes to Funding Opportunities

• Notice of Change to RFA-AG-21-016 Planning Projects for Clinical Trials on Effects of Sustained Reductions in Caloric Intake and Related Dietary Practices in Younger and Older Persons (U01 Clinical Trial Optional)
  (NOT-AG-20-049)
  National Institute on Aging
  

• Notice of Change to the Eligibility of Principal Investigators in PAR-20-042 : NCMRR Early Career Research Award (R03 Clinical Trial Optional
  (NOT-HD-20-030)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Correction to Eligibility Information for PAR-20-263 "Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)"
  (NOT-MH-20-090)
  National Institute of Mental Health
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional)
  (NOT-CA-20-098)
  National Cancer Institute
  

Notices of Special Interest

• Notice of Special Interest: Advancing the Science of Geriatric Palliative Care
  (NOT-AG-20-041)
  National Institute on Aging
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  Office of Research on Women's Health
  

• Notice of Special Interest: Emerging Viral Infections and their Impact on the Male and Female Reproductive Tract
  (NOT-HD-20-021)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Office of Research on Women's Health
  

• Notice of Special Interest: Optimizing Precision Treatment of Gynecologic, Reproductive and Obstetrical Outcomes in Adolescents and Adults with PCOS and Associated Comorbid Conditions (Clinical Trial Optional)
  (NOT-HD-20-026)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Office of Research on Women's Health
  

Funding Opportunities

• Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional)
  (PAR-20-302)
  National Cancer Institute
  National Institute on Minority Health and Health Disparities
  Office of Disease Prevention
  Application Receipt Date(s): November 12, 2020; thereafter, Standard dates apply.
  
  

• Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional)
  (PAR-20-303)
  National Cancer Institute
  Office of Disease Prevention
  Application Receipt Date(s): November 12, 2020; thereafter, Standard dates apply.
  
  

• HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)
  (PAR-21-024)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
  
  

• NIH Blueprint for Neuroscience Research: Functional Neural Circuits of Interoception (R01, Clinical Trial Not Allowed)
  (RFA-AT-21-003)
  National Center for Complementary and Integrative Health
  National Center for Advancing Translational Sciences
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): December 18, 2020
  
  

• Genomic Data Analysis Network: Genomic Data Analysis Center (U24 Clinical Trial Not Allowed)
  (RFA-CA-20-053)
  National Cancer Institute
  Application Receipt Date(s): November 12, 2020 No late applications will be accepted for this FOA.
  
  

• Toward ElucidAting MechanismS Contributing to HIV Reservoirs in NIDDK-relevant Tissues (Cure TEAMS) (R01 Clinical Trial Optional)
  (RFA-DK-20-023)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
  
  

• Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)
  (RFA-ES-20-014)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): February 15, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• NEI Audacious Goals Initiative: Translation-Enabling Models to Evaluate Survival and Integration of Regenerated Neurons in the Visual System (U24 Clinical Trial Not Allowed)
  (RFA-EY-20-001)
  National Eye Institute
  Application Receipt Date(s): January 15, 2021 No late applications will be accepted for this Funding Opportunity Announcement.
  
  

• Centers to Advance Research in Endometriosis (CARE) (P01 Clinical Trial Not Allowed)
  (RFA-HD-21-002)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Cancer Institute
  National Institute of Environmental Health Sciences
  Office of Research on Women's Health
  Application Receipt Date(s): November 30, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.